Compound information
- Natural Products
- NACP90786
- Molecular Formula
- C13H17NO4
- Molecular Weight
- 251.115758024 g/mol
- Structure
-
- IUPAC Name
- 2-(benzyloxycarbonylamino)pentanoic acid
- InChI
- InChI=1S/C13H17NO4/c1-2-6-11(12(15)16)14-13(17)18-9-10-7-4-3-5-8-10/h3-5,7-8,11H,2,6,9H2,1H3,(H,14,17)(H,15,16)
- InChI Key
- NSJDRLWFFAWSFP-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(C(=O)O)CCC
- CAS
- 21691-43-0
- SuperClass
- Benzenoids
- Class
- Benzene and substituted derivatives
- SubClass
- Benzyloxycarbonyls
- Source
- CNP0065170
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.301 |
LogS | -2.909 | LogD | 1.274 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.012 | Pgp substrate | 0.004 |
HIA | 0.894 | F20 % | 0.993 |
F30 % | 0.527 | Caco-2 | -5.025 |
MDCK | -4.749 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.982 | PPB | 82.943 |
VD | 0.364 | Fu | 0.526 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.005 | CYP1A2 substrate | 0.525 |
CYP2A6 substrate | 0.422 | CYP2B6 substrate | 0.462 |
CYP2C19 inhibitor | 0.02 | CYP2C19 substrate | 0.469 |
CYP2C8 substrate | 0.548 | CYP2C9 inhibitor | 0.047 |
CYP2C9 substrate | 0.501 | CYP2D6 inhibitor | 0.019 |
CYP2D6 substrate | 0.122 | CYP2E1 substrate | 0.266 |
CYP3A4 inhibitor | 0.026 | CYP3A4 substrate | 0.213 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.853 | CL | 1.641 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.436 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.02 |
FDAMDD | 0.028 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.002 |
Eye Irritation | 0.014 | Respiratory Toxicity | 0.006 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.009 | IGC50 | 2.448 |
LC50FM | 3.631 | LC50DM | 4.363 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.187 | NR-AR-LBD | 0.235 |
NR-AhR | 0.003 | NR-Aromatase | 0.047 |
NR-ER | 0.246 | NR-ER-LBD | 0.312 |
NR-PPAR-gamma | 0.503 | SR-ARE | 0.034 |
SR-ATAD5 | 0.317 | SR-HSE | 0.096 |
SR-MMP | 0.01 | SR-p53 | 0.018 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.